Mark For: REVELATION™ trademark registration is intended to cover the categories of house mark for pharmaceutical products for human use, namely, pharmaceuticals for the prevention and treatment of infectious diseases, pharmaceuticals for the prevention and treatment of respiratory viral infections, pharmaceuticals for the prevention and treatment of upper respiratory viruses, and pharmaceuticals for prevention and treatment of chronic nasal congestion; house mark for pharmaceuticals products for human use, namely, vaccines; diagnostic kits consisting primarily of reagents and assays for use in disease testing; medical diagnostic kits consisting primarily of reagents and assays for use in testing for levels of cytokines; medical diagnostic test strips for use in the field of infectious diseases; medical diagnostic test strips for use in testing for levels of cytokines.
Status
2021-09-21 UTC
LIVE APPLICATION Awaiting Examination
The trademark application has been accepted by the Office (has met the minimum filing requirements) and has not yet been assigned to an examiner.
(Pharmaceuticals) Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Filed Use
No
Current Use
No
Intent To Use
Yes
Filed ITU
Yes
44D Filed
No
44E Current
No
66A Current
No
Current Basis
No
No Basis
No
Attorney Name
Joshua S. Jarvis
Attorney Docket Number
37643.00003
Timeline
2021-09-17
Application Filed
2021-09-21
Location: NEW APPLICATION PROCESSING
2021-09-21
Status: Live/Pending
2021-09-21
Status: New application will be assigned to an examining attorney approximately 6 months after filing date.
JOSHUA S. JARVIS FOLEY HOAG LLP 155 SEAPORT BLVD. BOSTON, MA 02210-2600
Good, Services, and Codes
International Codes:
5
U.S. Codes:
005,006,018,044,046,051,052
International Codes:
10
U.S. Codes:
026,039,044
Type Code
Type
GS0051
House mark for pharmaceutical products for human use, namely, pharmaceuticals for the prevention and treatment of infectious diseases, pharmaceuticals for the prevention and treatment of respiratory viral infections, pharmaceuticals for the prevention and treatment of upper respiratory viruses, and pharmaceuticals for prevention and treatment of chronic nasal congestion; house mark for pharmaceuticals products for human use, namely, vaccines; diagnostic kits consisting primarily of reagents and assays for use in disease testing; medical diagnostic kits consisting primarily of reagents and assays for use in testing for levels of cytokines; medical diagnostic test strips for use in the field of infectious diseases; medical diagnostic test strips for use in testing for levels of cytokines
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.